Are proton pump inhibitors really so dangerous?

Area of Science:

• Gastroenterology
• Pharmacology
• Clinical Medicine

Background:

• Proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) are widely used for acid-related disorders.
• Recent observational studies suggest potential serious adverse events linked to chronic PPI use.

Purpose of the Study:

• To critically evaluate the evidence linking chronic PPI use to adverse events.
• To provide guidance on PPI use in light of recent pharmacovigilant findings.

Main Methods:

• Review and critical analysis of large-scale observational studies on PPIs.
• Assessment of methodological limitations including retrospective design, selection bias, and confounding factors.

Main Results:

• Recent studies on PPIs have methodological limitations, including retrospective designs and confounding factors.
• These limitations may overstate the risks associated with chronic PPI use.

Conclusions:

• Physicians should not be alarmed by recent findings and should continue prescribing PPIs for established indications.
• Switching to less effective H2RAs is not recommended due to potential patient harm and treatment failure.